BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu D, Chen Y, Wen S, Wen Y, Wang R, Zhang Q, Qin G, Yi H, Wu M, Lu L, Tao X, Deng X. Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer Cells. Nanoscale Res Lett 2019;14:314. [PMID: 31520223 DOI: 10.1186/s11671-019-3146-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Monu M, Sehrawat KD, Singh A, Chaudhary G, Bamal D, Sehrawat AR. An Overview on the therapeutic potential and Anticancer mechanism of Monacolin K / Lovastatin. Pharmacological Research - Modern Chinese Medicine 2022. [DOI: 10.1016/j.prmcm.2022.100187] [Reference Citation Analysis]
2 Sun Y, Fry CM, Shieh A, Cai X, Reardon TJ, Parquette JR. Self-assembly of a 5-fluorouracil and camptothecin dual drug dipeptide conjugate. Org Biomol Chem 2022. [PMID: 35734894 DOI: 10.1039/d2ob00762b] [Reference Citation Analysis]
3 Singh RS, Kaur N, Singh D, Bajaj BK, Kennedy JF. Downstream processing and structural confirmation of pullulan - A comprehensive review. Int J Biol Macromol 2022;208:553-64. [PMID: 35354070 DOI: 10.1016/j.ijbiomac.2022.03.163] [Reference Citation Analysis]
4 Tian X, He X, Yao A, You Y, Yang F, Chen K, Zhu C, Zeng M, Shi Q, Tang W, Fan X, Tao X. The properties of cholesterol-modified pullulan nanoparticles with different PEG coatings and their anti-hepatoblastoma cell effects. Materials Technology. [DOI: 10.1080/10667857.2022.2029288] [Reference Citation Analysis]
5 Halder U, Biswas R, Kabiraj A, Majhi K, Let M, Bandopadhyay R. Recent patents and current emergence of polysaccharides- based nanoparticles in medicine and drug delivery. Polysaccharide Nanoparticles 2022. [DOI: 10.1016/b978-0-12-822351-2.00007-3] [Reference Citation Analysis]
6 Li Y, Chen S, Zhu J, Zheng C, Wu M, Xue L, He G, Fu S, Deng X. Lovastatin enhances chemosensitivity of paclitaxel-resistant prostate cancer cells through inhibition of CYP2C8. Biochem Biophys Res Commun 2021;589:85-91. [PMID: 34896780 DOI: 10.1016/j.bbrc.2021.12.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ganie SA, Rather LJ, Li Q. A review on anticancer applications of pullulan and pullulan derivative nanoparticles. Carbohydrate Polymer Technologies and Applications 2021;2:100115. [DOI: 10.1016/j.carpta.2021.100115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
8 Xie L, Zhu G, Shang J, Chen X, Zhang C, Ji X, Zhang Q, Wei Y. An overview on the biological activity and anti-cancer mechanism of lovastatin. Cell Signal 2021;87:110122. [PMID: 34438015 DOI: 10.1016/j.cellsig.2021.110122] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Ye R, Sun L, Peng J, Wu A, Chen X, Wen L, Bai C, Chen G. Design, Synthesis, and Biological Evaluation of Dexamethasone-Salvianolic Acid B Conjugates and Nanodrug Delivery against Cisplatin-Induced Hearing Loss. J Med Chem 2021;64:3115-30. [PMID: 33666428 DOI: 10.1021/acs.jmedchem.0c01916] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Ashrafizadeh M, Rafiei H, Mohammadinejad R, Farkhondeh T, Samarghandian S. Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways. Cancer Cell Int 2021;21:66. [PMID: 33478512 DOI: 10.1186/s12935-021-01773-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 23.0] [Reference Citation Analysis]
11 Peipei D, Mansur K, Fu Y. Research development in tumor therapy: role of iron-related nanoparticles. E3S Web Conf 2021;251:02051. [DOI: 10.1051/e3sconf/202125102051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]